Asst. Prof. Bilgesu Onur SUCU

Publication Network

Journal articles indexed in SCI, SSCI, and AHCI

Synthesis of New Imidazo[1,2-a]pyridine Triazole Hybrid Molecules as Potential Apoptotic Antitumor Agents

Albayrak Halac F., Essiz S., Servili B., Altundas R., Sucu B. O., Kulu I.

ChemistrySelect , vol.9, no.8, 2024 (SCI-Expanded)

Development of light and pH-dual responsive self-quenching theranostic SPION to make EGFR overexpressing micro tumors glow and destroy.

Verimli N., Goralı S. İ., Abisoglu B., Altan C. L., Sucu B. O., Karatas E., et al.

Journal of photochemistry and photobiology. B, Biology , vol.248, pp.112797, 2023 (SCI-Expanded)

Synthesis of Novel Hybrid Lonidamine-Coumarin Derivatives and Their Anticancer Activities

Ipek Ö., Sucu B. O., Gül Ş., Yolaçan Ç., Güzel M.

Journal of Molecular Structure , vol.1281, 2023 (SCI-Expanded) Sustainable Development

Synthesis and Antiproliferative Evaluation of New 1,3,5-Trisubstituted 1,2,4-Triazole Derivatives against Glioblastoma Cell Lines

Koc E. B., SUCU B. O.

ChemistrySelect , vol.8, no.18, 2023 (SCI-Expanded)

Biological evaluation of imidazopyridine derivatives as potential anticancer agents against breast cancer cells

SUCU B. O.

Medicinal Chemistry Research , vol.31, no.12, pp.2231-2242, 2022 (SCI-Expanded)

Design and synthesis of novel caffeic acid phenethyl ester (CAPE) derivatives and their biological activity studies in glioblastoma multiforme (GBM) cancer cell lines

SUCU B. O., Koc E. B., Savlug Ipek Ö., Mirat A., Almas F., Guzel M. A., et al.

Journal of Molecular Graphics and Modelling , vol.113, 2022 (SCI-Expanded) Sustainable Development

Potential of Novel Methyl Jasmonate Analogs as Anticancer Agents to Metabolically Target HK-2 Activity in Glioblastoma Cells

Uludağ D., Bay S., SUCU B. O., Şavluğ İpek Ö., Mohr T., GÜZEL M., et al.

Frontiers in Pharmacology , vol.13, 2022 (SCI-Expanded) Sustainable Development

Synthesis of novel oxadiazole derivatives and their cytotoxic activity against various cancer cell lines

SUCU B. O., Koç E. B.

Turkish Journal of Chemistry , vol.46, no.4, pp.1089-1096, 2022 (SCI-Expanded)

Novel synthetic approaches for bisnaphthalimidopropyl (BNIP) derivatives as potential anti-parasitic agents for the treatment of leishmaniasis

Keskin E., Ucisik M. H., SUCU B. O., GÜZEL M.

Molecules , vol.24, no.24, 2019 (SCI-Expanded)

Synthesis of novel methyl jasmonate derivatives and evaluation of their biological activity in various cancer cell lines

SUCU B. O., Ipek Ö., Kurtulus S. O., Yazici B. E., KARAKAŞ N., GÜZEL M.

Bioorganic Chemistry , vol.91, 2019 (SCI-Expanded) Sustainable Development

Direct synthesis of imidazolidin-4-ones via cycloadditions of imines with a Leuchs' anyhdride

SUCU B. O., Ocal N., Erden I.

Tetrahedron Letters , vol.56, no.20, pp.2590-2592, 2015 (SCI-Expanded)

Synthesis of new tandospirone analogues carrying 1-(3-(trifluoromethyl) phenyl)piperazine

GÜNKARA Ö. T., SUCU B. O., Guleli M., Ocal N.

Synthetic Communications , vol.44, no.11, pp.1619-1628, 2014 (SCI-Expanded)

Synthesis of new aryl(hetaryl)-substituted tandospirone analogues with potential anxiolytic activity via reductive Heck type hydroarylations

GÜNKARA Ö. T., SUCU B. O., Ocal N., Kaufmann D. E.

Chemical Papers , vol.67, no.6, pp.643-649, 2013 (SCI-Expanded)

Synthesis of new aryl-substituted tandospirone and epiboxidine analogues and isoxazoline derivatives

Kulu I., Goksu G., SUCU B. O., Kopruceli A., Ocal N., Kaufmann D. E.

Organic Preparations and Procedures International , vol.45, no.1, pp.44-56, 2013 (SCI-Expanded)

Articles Published in Other Journals

New 8-Heterocyclic Xanthine Derivatives as Antiproliferative Agents: Synthesis and Biological Evaluation

Sucu B. O.

Journal of the Turkish Chemical Society, Section A: Chemistry , vol.11, no.2, pp.517-526, 2024 (Peer-Reviewed Journal)

Antileishmanial Activity of BNIPDaoct- and BNIPDanon-loaded Emulsomes on Leishmania infantum Parasites

Islek Z., Ucisik M. H., Keskin E., SUCU B. O., Gomes‐Alves A. G., Tomás A. M., et al.

Frontiers in Nanotechnology , vol.3, 2022 (Scopus)

Papers Presented at Peer-Reviewed Scientific Conferences

Synthesis and Biological Evaluation of Novel Imidazo[1,2-a]pyridine Triazole Hybrid Compounds

ALBAYRAK HALAÇ F., EŞSİZ Ş., SERVİLİ B., SUCU B. O., ALTUNDAŞ R., KULU İ.

12.International Drug Chemistry Conference, Antalya, Turkey, 7 - 10 March 2024, (Summary Text)

Design and Synthesis of Benzofuran/Heterocylic Hybrids as Potential Bioactive Agents

Sucu B. O.

12th International Drug Chemistry Conference, Antalya, Turkey, 7 - 10 March 2024, pp.131, (Summary Text)

Synthesis of novel pyrazolo[3,4-d]pyrimidine derivatives and investigation of their antiproliferative activities

KOÇ E. B., SUCU B. O.

19th Asian Chemical Congress, İstanbul, Turkey, 9 - 14 July 2023, (Summary Text)

Synthesis and Biological Evaluation of Novel Lonidamine Derivatives as Potential Antitumor Agents

ŞAVLUĞ İPEK Ö., SUCU B. O.

11th International Drug Chemistry Congress, Antalya, Turkey, 9 - 12 March 2023, (Summary Text)

SYNTHESIS OF NEW DUAL DRUG CANDIDATES THAT MAY HAVE THERAPEUTIC EFFECT AND DETERMINATION OF THEIR BIOLOGICAL ACTIVITIES

Şavluğ İpek Ö., SUCU B. O., GÜZEL M., YOLAÇAN Ç.

10th International Drug Chemistry Congress, Antalya, Turkey, 10 - 12 March 2022, (Summary Text)

Synthesis Of Novel Oxadiazole Derivatives And Their Cytotoxic Activity Against Various Cancer Cell Lines

KOÇ E. B., SUCU B. O.

10th International Drug Chemistry Congress, Antalya, Turkey, 10 - 13 March 2022, (Summary Text) Sustainable Development

Synthesis of novel triazole molecules and investigation of their apoptotic effects on glioblastoma multiforme cells

KOÇ E. B., SUCU B. O.

3rd International Cancer and Ion Channels Congress (CANCERION-2021), İstanbul, Turkey, 16 - 18 September 2021, (Summary Text)

Tripalmitin-based Emulsome Formulations for Sustained Delivery of Antileishmanial Compounds to Infected Macrophages

İŞLEK Z., SUCU B. O., KESKİN E., GÜZEL M., ŞAHİN F., ÜÇIŞIK M. H.

7th International BAU Drug Design Congress, İstanbul, Turkey, 19 - 21 December 2019, pp.75, (Summary Text)

Glioblastoma Multiform Hücre Hatlarında Özgün Kafeik Asit Fenetil Ester Analoglarının Anti-Kanser Etkisinin Araştırılması

SUCU B. O., Koç E. B., KARAKAŞ N., GÜZEL M.

7.International Drug Chemistry Conference, Antalya, Turkey, 14 March 2019, (Summary Text)

Therapeutic Effects of Novel Methyl Jasmonate Derivatives on Brain Cancer Cell Lines

Uludağ D., SUCU B. O., Şavluğ Ö., Yazıcı E., GÜZEL M., KARAKAŞ N.

3rd Annual Meeting MuTaLig COST Action, Malta, Italy, 18 October 2018, (Full Text)

Targeting different types of cancers by Novel Methyl Jasmonate Derivatives

YAZICI E., SUCU B. O., Şavluğ Ö., Uludağ D., KARAKAŞ N., GÜZEL M.

3rd Annual Meeting MuTaLig COST Action, Malta, Italy, 18 October 2018, (Summary Text)

Anti-cancer Effects of Novel Caffeic Acid Phenthyl Ester (CAPE) Analogues on Glioblastome Multiforme Cell Lines

Tosyalı İ. S., Öztür İ., Koç E. B., Güzel M. A., SUCU B. O., Şavluğ Ö., et al.

7. Multidisipliner Kanser Araştırma ve 1.Temel Onkoloji Kongresi (MOKAD 2018), İzmir, Turkey, 11 October 2018, (Summary Text)

Solid Lipid Emulsions for Delivery of Water-Insoluble Drug Candidates against Leishmaniasis

ÜÇIŞIK M. H., İŞLEK KÖKLÜ Z., Keskin E., SUCU B. O., GÜZEL M., ŞAHİN F.

CLINAM 2018: European Submit for Clinical Nanomedicine, Bazel, Switzerland, 2 - 05 September 2018, (Summary Text)

Emulsome-based targeted delivery of anti-leishmanial compounds to macrophages

İŞLEK Z., SUCU B. O., KESKİN E., GÜZEL M., ŞAHİN F., ÜÇIŞIK M. H.

11th European and Global Summit for Clinical Nanomedicine, Targeted Delivery and Precision Medicine – The Building Blocks to Personalized Medicine, Basel, Switzerland, 2 - 05 September 2018, pp.232-234, (Summary Text)

Novel Drug Discovery Approaches for Cancer with the Inspiration of a Natural Product - Methyl Jasmonate

SUCU B. O., Şavluğ Ö., ÖZDATLI Ş., GÜZEL M.

25th Biennial Congress of the European Association for Cancer Research (EACR25), Amsterdam, Netherlands, 30 June - 03 July 2018, (Summary Text) Sustainable Development

Tandospiron, Benzamid, Trisikloamino Asit Ester vePiridinoizoksazol Analoglarının Kanser Hücrelerinde İnhibitörEtkileri

ÖCAL SUNGUROĞLU Z. N., GÜNKARA Ö. T., SUCU B. O., NG Y. Y., GÜNAY F.

6. İlaç Kimyası: İlaç Etkin MaddesiTasarımı, Sentezi, Üretimi ve StandardizasyonuKongresi, Antalya, Turkey, 22 - 25 March 2018, (Summary Text) Sustainable Development

Hekzokinaz-2 Enzim İnhibitörü Özgün Metil Jasmonat Analoglarının Sentezi ve İn-Vitro Çalışmaları

SUCU B. O., Şavluğ Ö., ÖZDATLI Ş., GÜZEL M.

Uluslararası Katılımlı 6. İlaç Kimyası: İlaç Etkin Maddesi Tasarımı, Sentezi, Üretimi ve Standardizasyonu Kongresi, Antalya, Turkey, 22 - 25 March 2018, (Summary Text)

Prostat Kanserini Tedavi Etmek İçin Dosetaksel Konjuge, Prostat Spesifik Membran Antijen Hedefli Aptamer Komplekslerinin Geliştirilmesi

SUCU B. O., Hussein W., GÜZEL M.

Uluslararası Katılımlı 6. İlaç Kimyası: İlaç Etkin Maddesi Tasarımı, Sentezi, Üretimi ve Standardizasyonu Kongresi, Antalya, Turkey, 22 - 25 March 2018, (Summary Text) Sustainable Development

ANTI-PROLIFERATION ACTIVITY OF TANDOSPIRONE ANALOGUES IN TUMOR CELL LINES

GÜNKARA Ö. T., SUCU B. O., ÖCAL SUNGUROĞLU Z. N., Ng Y. Y., GÜNAY F., YILMAZ Z. H.

5th International Bahçeşehir University (BAU) Drug Design Congress, İstanbul, Turkey, 19 - 21 October 2017, (Summary Text)

Lipid-Based Emulsome Nanoformulations for Targeted Delivery of Antiparasites

ÜÇIŞIK M. H., İŞLEK KÖKLÜ Z., SUCU B. O., GÜZEL M., ŞAHİN F.

IV Symposium of Tropical Health / COST Action CM 1307 (WG3 and WG4) Joint Meeting, Pamplona, Spain, 4 - 05 May 2017, pp.1-82, (Summary Text)

Hekzokinaz-2 Enzim İnhibitörü Olarak Kullanılabilecek Anti-Kanser Ajanı Özgün Metil Jasmonat Analoglarının Sentezi ve İn-Vitro Çalışmaları

şavluğ ö., SUCU B. O., YOZGAT Y., GÜZEL M.

5. İLAÇ KİMYASI: İLAÇ ETKİN MADDESİ TASARIMI, SENTEZİ, ÜRETİMİ VE STANDARDİZASYONU KONGRESİ, Turkey, 30 March - 02 April 2017 Sustainable Development

Biyolojik Aktif Olabilecek L isolösin Grubu Taşıyan Amino Asid Amid Schiff Bazları ve İmidazolidin 4 on Bileşiklerinin One pot Sentezleri

GÜNKARA Ö. T., SUCU B. O., KAYA Z., ERDEN İ., ÖCAL SUNGUROĞLU Z. N.

III. Ulusal Organik Kimya Kongresi, Trabzon, Turkey, 5 - 08 September 2016, (Summary Text)

Leishmaniasis’in Tedavisine Yönelik Özgün İlaç Moleküllerinin Keşfi ve Geliştirme Çalışmaları

gölcük a., SUCU B. O., GÜZEL M., ÜÇIŞIK M. H.

III. Ulusal Organik Kimya Kongresi, Turkey, 5 - 08 September 2016

Özgün Anti-Kanser İlaç Adayı Keşif ve GeliştirmeÇalışmaları

SUCU B. O., GÜZEL M.

III. Ulusal Organik Kimya Kongresi, Turkey, 5 - 08 September 2016 Sustainable Development

Parkinson Hastalığı Tedavisi İçin Yeni A2A Adenosin Reseptör Antagonistlerinin Sentezi Ve Aktivitelerinin Değerlendirilmesi

ÖZDATLI Ş., SUCU B. O., GÜZEL M.

3.İlaç Kimyası: İlaç Etkin Maddesi Tasarımı, Sentezi, Üretimi ve Standardizasyonu Kongresi, Turkey, 20 - 22 March 2015, (Summary Text)

Synthesis of New Aryl Hetaryl Substituted Tandospirone Analogues Under Reductive Heck Type Hydroarylations with Expected Anxiolytic Activity

GÜNKARA Ö. T., SUCU B. O., ÖCAL SUNGUROĞLU Z. N., KAUFMANN D.

44th World Chemistry Congress, IUPAC, İstanbul, Turkey, 11 - 16 August 2013, (Summary Text)

Synthesis of New Aryl Substituted Tandospirone Analogues

ÖCAL SUNGUROĞLU Z. N., GÜNKARA Ö. T., SUCU B. O.

ESOC European Symposium on Organic Chemistry, Marsilya, France, 7 - 12 July 2013, (Summary Text)

Antidepresan ve Antipanik İlacı Olarak Kullanılan Tandospiron Molekülünün Daha Etkin Olabilecek Analoglarının Sentezlenmesi

KULU İ., SUCU B. O., GÜNKARA Ö. T., ÖCAL SUNGUROĞLU Z. N.

1. İlaç Kimyası, Üretimi, Teknolojisi ve Standardizasyonu Kongresi, Antalya, Turkey, 29 - 31 March 2013, (Summary Text)

Publications & Works